Close

Kura Oncology (KURA): Positive Phase II Data on tipifarnib - Oppenheimer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. BA
5. SPOT
6. META
7. V
8. IBM
9. KMB
10. GM


Go back to Kura Oncology (KURA): Positive Phase II Data on tipifarnib - Oppenheimer
(NASDAQ: KURA) Delayed: 18.75 +0.02 (0.11%)
Previous Close $18.73    52 Week High $8.90 
Open $18.75    52 Week Low $2.50 
Day High $18.92    P/E N/A 
Day Low $18.41    EPS $0.00 
Volume 816,008